StepStone Group LP TRDA Holdings History

Number of Shares
761,277.00
Current Holdings Value*
$6.88 Mil
% of Portfolio
7.07%
Total Estimate Gain
$-14.17 Mil
% of Total Estimate Gain
-70.89%

StepStone Group LP's Entrada Therapeutics Inc Holding Summary

As of 2025-03-31, StepStone Group LP held 761,277.00 shares of Entrada Therapeutics Inc(TRDA), totaling $6.88 Mil. This investment constitutes 7.07% of their stock portfolio, and StepStone Group LP now holds 2.01% of the outstanding Entrada Therapeutics Inc(TRDA) stock.

The initial trade took place in 2021Q4. And since then StepStone Group LP has made 2 purchases of TRDA, at an average price of $22.52, for a total of 887,595.00 shares. In addition, there have been 1 sales at an average price of $7.61 for 126,318.00 shares. Based on historical transaction data and TRDA's current price of $6.38, StepStone Group LP's estimated gain on his TRDA holdings is $-14.17 Mil, reflecting a -70.89% gain to date.

StepStone Group LP TRDA ($6.38) Holding Chart

StepStone Group LP TRDA ($6.38) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1